Immunogenicity, Reactogenicity and Safety of the Oral Live Attenuated Human Rotavirus Vaccine RIX4414(Rotarix™) Oral Suspension (Liquid Formulation) in Vietnamese Infants

被引：0
|
作者：
Anh, D. D. [1 ]
Thiem, V. D. [1 ]
Hutagalung, Y. [2 ]
Bock, H. L. [2 ]
Suryakiran, P. [2 ]
Delem, A. [2 ]
Han, H. H. [2 ]
机构：
[1] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam
[2] GlaxoSmithKline Biol, Rixensart, Belgium
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/j.ijid.2008.05.366
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E147 / E147
页数：1
相关论文
共 50 条
  • [31] Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
    Nigel Cunliffe
    Khalequ Zaman
    Carlos Rodrigo
    Serge Debrus
    Bernd Benninghoff
    Suryakiran Pemmaraju Venkata
    Htay-Htay Han
    [J]. BMC Pediatrics, 14
  • [32] The human rotavirus vaccine Rotarix™ in infants An integrated analysis of safety and reactogenicity
    Buyse, Hubert
    Vinals, Carlota
    Karkada, Naveen
    Han, Htay Htay
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (01) : 19 - 24
  • [33] Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine
    Dennehy, PH
    Brady, RC
    Halperin, SA
    Ward, RL
    Alvey, JC
    Fischer, FH
    Innis, BL
    Rathfon, H
    Schuind, A
    De Vos, B
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (06) : 481 - 488
  • [34] Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China Randomized, double-blind, placebo-controlled phase I studies
    Li, Rong-Cheng
    Li, Yan-Ping
    Mo, Zhao-Jun
    Luo, Dong
    Huang, Teng
    Kong, Ji-Lian
    Wang, Lao-Hong
    Song, Ning-Sheng
    Liu, Aixue
    Zhang, Helen
    Liao, Xueyan
    Karkada, Naveen
    Han, Htay Htay
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (08) : 1638 - 1642
  • [35] Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
    Rose, Johnie
    Hawthorn, Rachael L.
    Watts, Brook
    Singer, Mendel E.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 : 787 - 791
  • [36] Post-marketing safety surveillance conducted in Korea (2008-2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix)
    Shin, Son Moon
    Kim, Chun Soo
    Karkada, Naveen
    Liu, Aixue
    Jayadeva, Girish
    Han, Htay Htay
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (10) : 2590 - 2594
  • [37] Comparative evaluation of safety and immunogenicity of two dosages of oral live attenuated Human Rotavirus (HRV) Vaccine
    Dennehy, PH
    [J]. PEDIATRIC RESEARCH, 2004, 55 (04) : 339A - 339A
  • [38] Live Attenuated Human Rotavirus Vaccine, RIX4414, Provides Clinical Protection in Infants Against Rotavirus Strains With and Without Shared G and P Genotypes Integrated Analysis of Randomized Controlled Trials
    De Vos, Beatrice
    Han, Htay Htay
    Bouckenooghe, Alain
    Debrus, Serge
    Gillard, Paul
    Ward, Richard
    Cheuvart, Brigitte
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (04) : 261 - 266
  • [39] Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial
    Lau, Yu-Lung
    Nelson, E. Anthony S.
    Poon, Kin-Hung
    Chan, Paul K. S.
    Chiu, Susan
    Sung, Rita
    Leung, Chi Wai
    Ng, Daniel
    Ma, Yee Man
    Chan, Desmond
    Lee, Tsz Leung
    Tang, Joyce
    Kwan, Yat Wah
    Ip, Patricia
    Ho, Marco
    Fung, Lai-Wah Eva
    Tang, Haiwen
    Suryakiran, P. V.
    Han, Htay Htay
    Bock, Hans
    [J]. VACCINE, 2013, 31 (18) : 2253 - 2259
  • [40] Evaluation of RIX4414, A live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants
    Phua, KB
    Quak, SH
    Lee, BW
    Emmanuel, SC
    Goh, P
    Han, HH
    De Vos, B
    Bock, HL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 : S6 - S16
12345